| Original language | English |
|---|---|
| Pages (from-to) | 106-113 |
| Number of pages | 8 |
| Journal | Journal of Pharmaceutical and Biomedical Analysis |
| Volume | 149 |
| DOIs | |
| Publication status | Published - 5 Feb 2018 |
Keywords
- Everolimus
- Dried blood spot testing
- Analytical method
- Oncology
- UPLC-MS/MS
- Hematocrit
- TANDEM MASS-SPECTROMETRY
- RENAL-CELL CARCINOMA
- NEUROENDOCRINE TUMORS
- CYCLOSPORINE-A
- SAMPLES
- HEMATOCRIT
- TACROLIMUS
- SIROLIMUS
- EXPOSURE
- CANCER
Cite this
}
Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting. / Knapen, Lotte M.; de Beer, Yvo; Bruggemann, Roger J. M.; Stolk, Leo M.; de Vries, Frank; Tjan-Heijnen, Vivianne C. G.; van Erp, Nielka P.; Croes, Sander.
In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 149, 05.02.2018, p. 106-113.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting
AU - Knapen, Lotte M.
AU - de Beer, Yvo
AU - Bruggemann, Roger J. M.
AU - Stolk, Leo M.
AU - de Vries, Frank
AU - Tjan-Heijnen, Vivianne C. G.
AU - van Erp, Nielka P.
AU - Croes, Sander
PY - 2018/2/5
Y1 - 2018/2/5
KW - Everolimus
KW - Dried blood spot testing
KW - Analytical method
KW - Oncology
KW - UPLC-MS/MS
KW - Hematocrit
KW - TANDEM MASS-SPECTROMETRY
KW - RENAL-CELL CARCINOMA
KW - NEUROENDOCRINE TUMORS
KW - CYCLOSPORINE-A
KW - SAMPLES
KW - HEMATOCRIT
KW - TACROLIMUS
KW - SIROLIMUS
KW - EXPOSURE
KW - CANCER
U2 - 10.1016/j.jpba.2017.10.039
DO - 10.1016/j.jpba.2017.10.039
M3 - Article
VL - 149
SP - 106
EP - 113
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
SN - 0731-7085
ER -